Background: There are multiple case reports in the literature describing an association between fingolimod and cutaneous neoplasms.
Objective: Investigate and report a case of a primary mediastinal large B-cell lymphoma in a patient on fingolimod for Relapsing-Remitting Multiple Sclerosis (RRMS).
Methods: Case Report.